{
  "status" : "final",
  "category" : {
    "text" : "Laboratory",
    "coding" : [
      {
        "system" : "http://hl7.org/fhir/observation-category",
        "display" : "Laboratory",
        "code" : "laboratory"
      }
    ]
  },
  "issued" : "2023-01-10T13:44:15Z",
  "id" : "TYcMmvyAsEe9z0dLTxywv5hJ.zrImeXhf1IWRIDZxTyayshP8TbHvZKzPczndsfvAB",
  "code" : {
    "text" : "AH NON-HDL CHOLESTEROL (MG/DL)",
    "coding" : [
      {
        "system" : "http://loinc.org",
        "display" : "Cholesterol non HDL [Mass/volume] in Serum or Plasma",
        "code" : "43396-1"
      }
    ]
  },
  "valueQuantity" : {
    "code" : "mg/dL",
    "value" : 164,
    "system" : "http://unitsofmeasure.org",
    "unit" : "mg/dL"
  },
  "subject" : {
    "display" : "Lopez, James Joel",
    "reference" : "https://epicproxy.et0905.epichosted.com/FHIRProxy/api/FHIR/DSTU2/Patient/TrS7pTeyWII9cw-xxl5jDrPczC4c5dkg8XOYg4BocZ84B"
  },
  "comments" : "Atherosclerotic Cardiovascular Disease Risk Categories and Non-HDL Cholesterol Goals: \r\n    Patient Risk        Goal\r\n      Low Risk:     < 160 mg/dL\r\n Moderate Risk:     < 130 mg/dL\r\n     High Risk:     < 130 mg/dL\r\nVery High Risk:     < 100 mg/dL\r\n  Extreme Risk:     < 80 mg/dL\r\n\r\nAmerican Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for management of dyslipidemia and prevention of cardiovascular disease. Endocrine Practice Vol 23 (Sup 2) April 2017.",
  "effectiveDateTime" : "2023-01-10T13:44:00Z",
  "resourceType" : "Observation"
}